Kopran Limited (NSE:KOPRAN)

Market Cap	9.26B
Revenue (ttm)	6.31B
Net Income (ttm)	385.52M
Shares Out	n/a
EPS (ttm)	7.99
PE Ratio	24.02
Forward PE	n/a
Dividend	3.00 (1.56%)
Ex-Dividend Date	Sep 2, 2024

Volume	105,937
Average Volume	233,616
Open	190.55
Previous Close	192.13
Day's Range	187.96 - 191.96
52-Week Range	155.00 - 369.70
Beta	0.69
RSI	52.49
Earnings Date	May 16, 2025

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pa...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 842
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KOPRAN

Financial Performance

In 2024, Kopran's revenue was 6.31 billion, an increase of 2.72% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.